Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report

Oliveira, Felipe Araújo Andrade de; Filho, José Ricardo Bandeira de Oliveira; Rocha-Filho, Pedro Augusto Sampaio

doi:10.1007/s13365-021-01024-5

Cited by 6 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 A demyelinating neuropathy, Lewis-Sumner syndrome, has also been described 3 months after COVID-19. 18 In the analysis of the risk of bias, the Newcastle Ottawa scale 13 was used in 2 studies, the first obtained a score in the selection of 2, in the comparison of 2, and in the outcome of 2. 15 The other study was obtained in selection 3, comparison 2, and outcome 2.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature

Gomes,

Martins,

Pacheco

et al. 2024

Arq Neuropsiquiatr

View full text Add to dashboard Cite

Background The post-COVID-19 condition is a major modern challenge in medicine and has a high global impact on the health of the population. Objective To determine the main neurological and neuropsychiatric manifestations after acute COVID-19 infection in South American countries. Methods This is a systematic review study, registered on the PROSPERO platform following the PRISMA model. 4131 articles were found with the search strategies used. Neurological and neuropsychiatric manifestations were investigated in individuals three months or more after acute COVID-19 infection, and older than 18 years, including studies conducted in South American countries published between 2020 and 2022. Results Six studies (four from Brazil and two from Ecuador) were analyzed. Regarding the type of study: three were cohorts, two were case reports, and one was cross-sectional. The main outcomes found were new pain (65.5%) and new chronic pain (19.6%), new headache (39.1%), daily chronic headache (13%), paresthesia (62%), in addition to neuropsychiatric diseases, such as generalized anxiety disorder (15.1%), post-traumatic stress syndrome (13.4%), depression and anxiety (13.5%), suicidal ideation (10.1%), and several cognitive disorders. Conclusion Neurological and neuropsychiatric manifestations related to depression and anxiety, and cognition disorders are reported during the post-COVID-19 condition in South America. Symptoms associated with chronic pain appear to be associated with the condition. More studies on post-COVID-19 conditions are needed in the South America region.

show abstract

Section: Resultsmentioning

confidence: 99%

“… 17 A demyelinating neuropathy, Lewis-Sumner syndrome, has also been described 3 months after COVID-19. 18 …”

Section: Resultsmentioning

confidence: 99%

Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature

Gomes,

Martins,

Pacheco

et al. 2024

Arq Neuropsiquiatr

View full text Add to dashboard Cite

show abstract

“…Multiple case reports in the literature have reported that lumbar puncture is contraindicated, and therefore CSF could not be obtained for SARS-CoV-2 testing [ 51 , 52 ]. In addition, there were many cases where lumbar puncture was performed but CSF was not tested for SARS-CoV-2 without providing justifications for not testing [ 53 , 54 , 55 , 56 ]. Other case studies reported that CSF samples were not tested for COVID-19 because there is no Food and Drug Administration (FDA) approved PCR kit or a commercially available kit for SARS-CoV-2 diagnosis in CSF [ 57 , 58 ].…”

Section: Discussionmentioning

confidence: 99%

Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports

Elmakaty

Ferih

Karen

et al. 2022

Cells

View full text Add to dashboard Cite

This systematic review focused on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients that had detected SARS-CoV-2 virus in cerebrospinal fluid (CSF). A systematic literature search was carried out in PubMed, Embase, Scopus, Web of Science, Medrxiv, and Biorxiv databases from inception to 19 December 2021. Case reports or case series involving patients with proved SARS-CoV-2 presence in CSF by polymerize chain reaction were included. Our search strategy produced 23 articles documenting a total of 23 patients with positive SARS-CoV-2 in the CSF. Fever (55%) was the most common symptom, followed by headaches (41%), cough (32%), and vomiting/nausea (32%). The majority of the cases included was encephalitis (57%), 8 of which were confirmed by magnetic resonance imaging. The second most prevalent presentation was meningitis. The cerebral spinal fluid analysis found disparities in protein levels and normal glucose levels in most cases. This study demonstrates that SARS-CoV-2 can enter the nervous system via various routes and cause CNS infection symptoms. SARS-CoV-2 has been shown to infect the CNS even when no respiratory symptoms are present and nasopharyngeal swabs are negative. As a result, SARS-CoV-2 should be considered as a possible cause of CNS infection and tested for in the CSF.

show abstract

Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study

Magalhães

Rocha-Filho

2023

J. Neurovirol.

View full text Add to dashboard Cite

Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report

Cited by 6 publications

References 9 publications

Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature

Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: a systematic review of the literature

Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports

Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study

Contact Info

Product

Resources

About